Endobrachyesophagus Without Mucosectomy: An Experimental Model in Dogs

  • Benjamin Narbona-Arnau
  • Pilar Argente-Navarro
  • Jose Miguel Lloris-Carsí
  • Miguel Angel Calvo-Bermúdez
  • Dolores Cejalvo-Lapeña
Conference paper


Barrett’s esophagus is regarded us a precancerous disease, with a neoplastic degenerative tendency some 40 times that of the normal mucosa [1]. The condition lacks efficient medical treatment and antireflux surgery is insufficient and controversial. In turn, prophylaxis, involving endoscopic control and biopsies to afford curative exeresis or preventive resection, is both problematic and unsatisfactory, since endoscopy-biopsy is uncertain and expensive, while esophagectomy involves excessive morbidity and mortality.


Lower Esophageal Sphincter Antireflux Surgery Reflux Episode Duodenal Content Endoscopic Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tygat GNS (1992) Incidence of cancer in esophageal columnar metaplasia (Barrett’s esophagus). Dis Esoph 5: 29–35Google Scholar
  2. 2.
    Skinner DB (1990) Controversies about Barrett’s esophagus. Ann Thorac Surg 49: 523–524PubMedCrossRefGoogle Scholar
  3. 3.
    Giuli R, De Vathaire F (1988) OESO collaborative studies. Launching of a international study on esophagitis: Barrett’s esophagus and esophageal dysphasia. Dis Esoph 1: 139–146Google Scholar
  4. 4.
    Hennessy TPJ, Edlich RF, Buchin RJ, et al (1968) Influence of gastroesophageal incompetence on regeneration of oesophageal mucosa. Arch Surg 95: 105–107Google Scholar
  5. 5.
    Bremner CG, Lynch VP, Ellis FM (1970) Barrett’s esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in dog. Surgery 68: 209–216PubMedGoogle Scholar
  6. 6.
    Bremner CG (1982) Benign strictures of the esophagus. Curr Prob Surg 19: 460–449CrossRefGoogle Scholar
  7. 7.
    Martin CJ, Funk NA, Ewing ME, et al (1992) Reversal of experimental Barrett’s esophagus by endoscopic laser ablation and reduction of acid reflux. Fifth World Congress ISDE, 5–8 August 1992, Kyoto. Abstracts SP 151 p 188Google Scholar
  8. 8.
    Pollara WM, Zilberstein B, Cercoconello I, Filho UL, Pinotti HW (1985) Regeneration of eophageal epithelium in the presence of gastroesophageal reflux. In: DeMeester TR, Skinner DB (eds) Esophageal disorders: Pathophysiology and therapy, Raven, New YorkGoogle Scholar
  9. 9.
    Guillen P, West AB, Keeling P, Hennessy TPJ (1988) Barrett’s oesophagus: A pathophysiological study. In: Sie wert JR, Hölschner AH (eds) Diseases of the esophagus. Springer, Berlin Heidelberg New York, pp 540–541Google Scholar
  10. 10.
    Pera M, Cardesa A, Bombi JA, Ernst H, Pera C, Mohr U (1989) Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res 49: 6803–6808PubMedGoogle Scholar
  11. 11.
    Attwood SFA, Smyrk ThC, DeMeester TR, et al (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111: 503–510PubMedGoogle Scholar
  12. 12.
    Pera M, Cardesa A, Bombi JA, Ernst H, Pera C, Mohr U (1989) Experimental adenocarcinoma of the distal esophagus after exposure to 2,6-dimethylnitrosomorpholine under the influence of reflux esophagitis. Fourth World Congress ISDE, 6–8 Sept. 1989, Chicago. Abstracts p 100Google Scholar
  13. 13.
    Streitz JM, Ellis FH, Gibb SP, et al. (1991) Adenocarcinoma in Barrett’s esophagus: a clinical pathologic study of 65 cases. Ann Surg 313: 122–125CrossRefGoogle Scholar
  14. 14.
    Schneider PM, Casson AG, Roth JA (1992) Dectection of malignant potential in Barrett’s epithelium. Dis Esoph 5: 45–50Google Scholar
  15. 15.
    Siewert JR, Hölscher AH, Bollschweller E (1992) Surgical therapy of cancer in Barrett’s esophagus. Dis Esoph 5: 57–62Google Scholar
  16. 16.
    Achkar E, Carey WC (1988) The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. Am J Gastroenterol 81: 580–584Google Scholar
  17. 17.
    Appelman HD, Kallsh RJ, Chancy PE, Orringer MB (1985) Distinguishing features of adenocarcinoma in Barrett’s esophagus and in the gastric cardia. In: Spechler SJ, Goyal RK (eds) Barrett’s Esophagus. Pathophysiology, diagnosis and management. Elsevier, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Benjamin Narbona-Arnau
  • Pilar Argente-Navarro
  • Jose Miguel Lloris-Carsí
  • Miguel Angel Calvo-Bermúdez
  • Dolores Cejalvo-Lapeña
    • 1
  1. 1.Centro de Investigación Hospital General UniversitarioValenciaSpain

Personalised recommendations